The DOI matches its Crossref record; 155 of the 155 references it cites were found in a registry or an index.
Candida glabrata: a review of its features and resistance
Open accessAbstract
Candida species belong to the normal microbiota of the oral cavity and gastrointestinal and vaginal tracts, and are responsible for several clinical manifestations, from mucocutaneous overgrowth to bloodstream infections. Once believed to be non-pathogenic, Candida glabrata was rapidly blamable for many human diseases. Year after year, these pathological circumstances are more recurrent and problematic to treat, especially when patients reveal any level of immunosuppression. These difficulties arise from the capacity of C. glabrata to form biofilms and also from its high resistance to traditional antifungal therapies. Thus, this review intends to present an excerpt of the biology, epidemiology, and pathology of C. glabrata, and detail an approach to its resistance mechanisms based on studies carried out up to the present.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The first step of C. glabrata biofilm development is adhesion and/or colonisation of yeast cells to an abiotic or/and biotic surface [4,10].”
From Candida glabrata Biofilms: How Far Have We Come? (2017) · cites this paper as [10]
In the citing paper
“In addition to the high antifungal drugs resistance and inability to form hyphae or secret hydrolases, C. glabrata retain many virulence factors”
From Candida glabrata Biofilms: How Far Have We Come? (2017) · cites this paper as [10]
In the citing paper
“C. glabrata retain many virulence factors that contribute to its extreme aggressiveness and result in a low therapeutic response and serious recurrent candidiasis”
From Candida glabrata Biofilms: How Far Have We Come? (2017) · cites this paper as [10]
In the citing paper
“For their extraordinary organization, especially regarding the complex structure of the matrix, biofilms are very resistant to antifungal treatments.”
From Candida glabrata Biofilms: How Far Have We Come? (2017) · cites this paper as [10]
In the citing paper
“particularly biofilm formation ability”
From Candida glabrata Biofilms: How Far Have We Come? (2017) · cites this paper as [10]
Citations
Cites
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174 · cited 1×
“17 different Candida species are known to be etiological agents of human infections; however, more than 90 % of invasive infections are due to Candida species [5].”
Mechanisms of biofilm resistance to antimicrobial agents
Mah, T.-F. C., & O'Toole, G. A. (2001) · Trends in Microbiology · doi:10.1016/s0966-842x(00)01913-2 · Cited by 3,921
International Study of the Prevalence and Outcomes of Infection in Intensive Care Units
Vincent, J. (2009) · JAMA · doi:10.1001/jama.2009.1754 · Cited by 3,639
How long do nosocomial pathogens persist on inanimate surfaces? A systematic review
Krämer, A., Schwebke, I., & Kampf, G. (2006) · BMC Infectious Diseases · doi:10.1186/1471-2334-6-130 · Cited by 2,508
Autophagosome formation: core machinery and adaptations
Xie, Z., & Klionsky, D. J. (2007) · Nature Cell Biology · doi:10.1038/ncb1007-1102 · Cited by 2,237
Lewis, K. (2010) · Annual Review of Microbiology · doi:10.1146/annurev.micro.112408.134306 · Cited by 1,858
Molecular evidence for an ancient duplication of the entire yeast genome
Wolfe, K. H., & Shields, D. C. (1997) · Nature · doi:10.1038/42711 · Cited by 1,785
Segal, A. W. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115653 · Cited by 1,783
Dujon, B., Sherman, D., Fischer, G., Durrens, P., Casaregola, S., Lafontaine, I., de Montigny, J., Marck, C., Neuvéglise, C., Talla, E., et al. (2004) · Nature · doi:10.1038/nature02579 · Cited by 1,623
Chandra, J., Kuhn, D. M., Mukherjee, P. K., Hoyer, L. L., McCormick, T., & Ghannoum, M. A. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.18.5385-5394.2001 · Cited by 1,578
Odds, F. C. (1979) · Medical Entomology and Zoology · Cited by 1,297
Sardi, J. C. O., Scorzoni, L., Bernardi, T., Fusco-Almeida, A. M., & Mendes Giannini, M. J. S. (2013) · Journal of Medical Microbiology · doi:10.1099/jmm.0.045054-0 · Cited by 1,184
Evolution of pathogenicity and sexual reproduction in eight Candida genomes
Butler, G., Rasmussen, M. D., Lin, M. F., Santos, M. A. S., Sakthikumar, S., Munro, C. A., Rheinbay, E., Grabherr, M., Forche, A., Reedy, J. L., et al. (2009) · Nature · doi:10.1038/nature08064 · Cited by 1,065
Candida Infections of Medical Devices
Kojic, E. M., & Darouiche, R. O. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.2.255-267.2004 · Cited by 1,055
Silva, S., Negri, M., Henriques, M., Oliveira, R., Williams, D. W., & Azeredo, J. (2012) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00278.x · Cited by 969
Self-citationFidel, P. L., Vazquez, J. A., & Sobel, J. D. (1999) · Clinical Microbiology Reviews · doi:10.1128/cmr.12.1.80 · Cited by 953
Calderone, R. (2012) · ASM Press eBooks · Cited by 912
Multidrug Tolerance of Biofilms and Persister Cells
Lewis, K. (2008) · Current topics in microbiology and immunology · doi:10.1007/978-3-540-75418-3_6 · Cited by 838
Alexander, B. D., Johnson, M. D., Pfeiffer, C. D., Jiménez-Ortigosa, C., Catania, J., Booker, R., Castanheira, M., Messer, S. A., Perlin, D. S., & Pfaller, M. A. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit136 · Cited by 778
Standardized Method for In Vitro Antifungal Susceptibility Testing of Candida albicans Biofilms
Ramage, G., Vande Walle, K., Wickes, B. L., & López-Ribot, J. L. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.9.2475-2479.2001 · Cited by 753
Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance
Krcmery, V., & Barnes, A. J. (2002) · Journal of Hospital Infection · doi:10.1053/jhin.2001.1151 · Cited by 733
Transcriptional Response of Candida albicans upon Internalization by Macrophages
Lorenz, M. C., Bender, J. A., & Fink, G. R. (2004) · Eukaryotic Cell · doi:10.1128/ec.3.5.1076-1087.2004 · Cited by 712
Oppenheim, F. G., Xu, T., McMillian, F. M., Levitz, S. M., Diamond, R. D., Offner, G. D., & Troxler, R. F. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68522-9 · Cited by 652
Brandt, M. E. (2002) · Emerging infectious diseases · doi:10.3201/eid0808.020059 · Cited by 646
Intragenic tandem repeats generate functional variability
Verstrepen, K. J., Jansen, A., Lewitter, F., & Fink, G. R. (2005) · Nature Genetics · doi:10.1038/ng1618 · Cited by 616
Antifungal Resistance of Candidal Biofilms Formed on Denture Acrylic in vitro
Chandra, J., Mukherjee, P. K., Leidich, S. D., Faddoul, F., Hoyer, L. L., Douglas, L., & Ghannoum, M. A. (2001) · Journal of Dental Research · doi:10.1177/00220345010800031101 · Cited by 588
Ramage, G., Rajendran, R., Sherry, L., & Williams, C. (2012) · International Journal of Microbiology · doi:10.1155/2012/528521 · Cited by 583
Yap1 and Skn7 Control Two Specialized Oxidative Stress Response Regulons in Yeast
Lee, J., Godon, C., Lagniel, G., Spector, D., Garin, J., Labarre, J., & Tolédano, M. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.23.16040 · Cited by 567
How to build a biofilm: a fungal perspective
Blankenship, J. R., & Mitchell, A. P. (2006) · Current Opinion in Microbiology · doi:10.1016/j.mib.2006.10.003 · Cited by 530
Candida albicans Biofilms Produce Antifungal-Tolerant Persister Cells
LaFleur, M. D., Kumamoto, C. A., & Lewis, K. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00684-06 · Cited by 521
Candida albicans, a major human fungal pathogen
Kim, J., & Sudbery, P. E. (2011) · The Journal of Microbiology · doi:10.1007/s12275-011-1064-7 · Cited by 506
Dispersion as an Important Step in the Candida albicans Biofilm Developmental Cycle
Uppuluri, P., Chaturvedi, A. K., Srinivasan, A., Banerjee, M., Ramasubramaniam, A. K., Köhler, J. R., Kadosh, D., & Lopez-Ribot, J. L. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000828 · Cited by 432
Pfaller, M. A., & Diekema, D. J. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1470-9465.2004.t01-1-00844.x · Cited by 422
Françoise Van Bambeke, A., Balzi, E., & Tulkens, P. M. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00291-4 · Cited by 404
Rippon, J. W. (1989) · JAMA · doi:10.1001/jama.1989.03430190139055 · Cited by 398
Biofilms of non-Candida albicans Candida species: quantification, structure and matrix composition
Silva, S., Henriques, M., Martins, A., Oliveira, R., Williams, D., & Azeredo, J. (2009) · Medical Mycology · doi:10.3109/13693780802549594 · Cited by 390
Self-citationHuman Saliva: Clinical Chemistry and Microbiology
Tenovuo, J. O. (2021) · CRC Press eBooks · doi:10.1201/9781003210399 · Cited by 388
An Adhesin of the Yeast Pathogen Candida glabrata Mediating Adherence to Human Epithelial Cells
Cormack, B. P., Ghori, N., & Falkow, S. (1999) · Science · doi:10.1126/science.285.5427.578 · Cited by 383
A Saccharomyces gene family involved in invasive growth, cell–cell adhesion, and mating
Guo, B., Styles, C. A., Feng, Q., & Fink, G. R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.220420397 · Cited by 382
Pfaller, M. A., Castanheira, M., Lockhart, S. R., Ahlquist, A. M., Messer, S. A., & Jones, R. N. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.06112-11 · Cited by 377
The changing face of epidemiology of invasive fungal disease in Europe
Lass‐Flörl, C. (2009) · Mycoses · doi:10.1111/j.1439-0507.2009.01691.x · Cited by 371
Sundstrom, P. (2002) · Cellular Microbiology · doi:10.1046/j.1462-5822.2002.00206.x · Cited by 336
Epidemiological trends in nosocomial candidemia in intensive care
Bassetti, M., Righi, E., Costa, A., Fasce, R., Molinari, M. P., Rosso, R., Pallavicini, F. B., & Viscoli, C. (2006) · BMC Infectious Diseases · doi:10.1186/1471-2334-6-21 · Cited by 332
Adherence and biofilm formation of non-Candida albicans Candida species
Silva, S., Negri, M., Henriques, M., Oliveira, R., Williams, D. W., & Azeredo, J. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2011.02.003 · Cited by 304
Self-citationFunctional and Structural Diversity in the Als Protein Family of Candida albicans
Sheppard, D. C., Yeaman, M. R., Welch, W. H., Phan, Q. T., Fu, Y., Ibrahim, A. S., Filler, S. G., Zhang, M., Waring, A. J., & Edwards, J. E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401929200 · Cited by 300
An update on antifungal targets and mechanisms of resistance in Candidaalbicans
Akins, R. A. (2005) · Medical Mycology · doi:10.1080/13693780500138971 · Cited by 291
A Candida Biofilm-Induced Pathway for Matrix Glucan Delivery: Implications for Drug Resistance
Taff, H. T., Nett, J. E., Zarnowski, R., Ross, K. M., Sanchez, H., Cain, M. T., Hamaker, J., Mitchell, A. P., & Andes, D. R. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002848 · Cited by 291
Vermitsky, J.-P., & Edlind, T. D. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.10.3773-3781.2004 · Cited by 285
Kaur, R., Ma, B., & Cormack, B. P. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611195104 · Cited by 284
A yeast by any other name: Candida glabrata and its interaction with the host
Kaur, R., Domergue, R., Zupancic, M. L., & Cormack, B. P. (2005) · Current Opinion in Microbiology · doi:10.1016/j.mib.2005.06.012 · Cited by 271
De Las Peñas, A., Pan, S.-J., Castaño, I., Alder, J., Cregg, R., & Cormack, B. P. (2003) · Genes & Development · doi:10.1101/gad.1121003 · Cited by 268
Cox, G. M., Harrison, T. S., McDade, H. C., Taborda, C. P., Heinrich, G., Casadevall, A., & Perfect, J. R. (2002) · Infection and Immunity · doi:10.1128/iai.71.1.173-180.2003 · Cited by 267
Nicotinic Acid Limitation Regulates Silencing of Candida Adhesins During UTI
Domergue, R., Castaño, I., De Las Peñas, A., Zupancic, M., Lockatell, V., Hebel, J. R., Johnson, D., & Cormack, B. P. (2005) · Science · doi:10.1126/science.1108640 · Cited by 249
Two unlike cousins: Candida albicans and C . glabrata infection strategies
Brunke, S., & Hube, B. (2013) · Cellular Microbiology · doi:10.1111/cmi.12091 · Cited by 239
Patients with Long-Term Oral Carriage Harbor High-Persister Mutants of Candida albicans
LaFleur, M. D., Qi, Q., & Lewis, K. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00860-09 · Cited by 237
Evolution of the MAT locus and its Ho endonuclease in yeast species
Butler, G., Kenny, C. C., Fagan, A., Kurischko, C., Gaillardin, C. M., & Wolfe, K. H. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0304170101 · Cited by 236
Penetration of Candida Biofilms by Antifungal Agents
Al-Fattani, M. A., & Douglas, L. J. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.9.3291-3297.2004 · Cited by 235
de Groot, P. W. J., Kraneveld, E. A., Yin, Q. Y., Dekker, H. L., Groß, U., Crielaard, W., de Koster, C. G., Bader, O., Klis, F. M., & Weig, M. (2008) · Eukaryotic Cell · doi:10.1128/ec.00284-08 · Cited by 232
Seider, K., Brunke, S., Schild, L., Jablonowski, N., Wilson, D., Majer, O., Barz, D., Haas, A., Kuchler, K., Schaller, M., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003730 · Cited by 220
Mechanism of Increased Fluconazole Resistance in Candida glabrata during Prophylaxis
Bennett, J. E., Izumikawa, K., & Marr, K. A. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.5.1773-1777.2004 · Cited by 217
Upregulation of ERG Genes in Candida Species by Azoles and Other Sterol Biosynthesis Inhibitors
Henry, K. W., Nickels, J. T., & Edlind, T. D. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.10.2693-2700.2000 · Cited by 216
Candida albicans drug resistance—Another way to cope with stress
Cannon, R. D., Lamping, E., Holmes, A. R., Niimi, K., Tanabe, K., Niimi, M., & Monk, B. C. (2007) · Microbiology · doi:10.1099/mic.0.2007/010405-0 · Cited by 208
Biofilm formation in clinical Candida isolates and its association with virulence
Hasan, F., Xess, I., Wang, X., Jain, N., & Fries, B. C. (2009) · Microbes and Infection · doi:10.1016/j.micinf.2009.04.018 · Cited by 206
Reagan, D. R., Pfaller, M. A., Hollis, R. J., & Wenzel, R. P. (1990) · Journal of Clinical Microbiology · doi:10.1128/jcm.28.12.2733-2738.1990 · Cited by 205
Telomere length control and transcriptional regulation of subtelomeric adhesins in Candida glabrata
Castaño, I., Pan, S., Zupancic, M., Hennequin, C., Dujon, B., & Cormack, B. P. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2004.04465.x · Cited by 188
Production of extracellular matrix by Candida albicans biofilms
Hawser, S., Baillie, G. S., & Douglas, L. (1998) · Journal of Medical Microbiology · doi:10.1099/00222615-47-3-253 · Cited by 184
Parallel inactivation of multiple GAL pathway genes and ecological diversification in yeasts
Hittinger, C. T., Rokas, A., & Carroll, S. B. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404319101 · Cited by 178
Shields, R. K., Nguyen, M. H., Press, E. G., Kwa, A. L., Cheng, S., Du, C., & Clancy, C. J. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00027-12 · Cited by 171
Antifungal drug resistance of oral fungi
Niimi, M., Firth, N. A., & Cannon, R. D. (2010) · Odontology · doi:10.1007/s10266-009-0118-3 · Cited by 170
Candida biofilms: antifungal resistance and emerging therapeutic options.
Kuhn, D. M., & Ghannoum, M. A. (2004) · PubMed · Cited by 168
Kaur, R., Castaño, I., & Cormack, B. P. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.5.1600-1613.2004 · Cited by 167
Nosocomial Acquisition of Candida albicans: An Epidemiologic Study
Vázquez, J. A., Sánchez, V., Dmuchowski, C., Dembry, L. M., Sobel, J. D., & Zervos, M. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/168.1.195 · Cited by 165
Role for Cell Density in Antifungal Drug Resistance in Candida albicans Biofilms
Perumal, P., Mekala, S., & Chaffin, W. L. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01237-06 · Cited by 165
Transient-state analysis of metabolic fluxes in crabtree-positive and crabtree-negative yeasts
Van Urk, H., Voll, W. S. L., Scheffers, W. A., & Van Dijken, J. P. (1990) · Applied and Environmental Microbiology · doi:10.1128/aem.56.1.281-287.1990 · Cited by 163
Klionsky, D. J. (2005) · Current Biology · doi:10.1016/j.cub.2005.04.013 · Cited by 163
Colombo, A. L., Guimarães, T., Silva, L. R. B. F., de Almeida, L. P., Cunha, A. K. B., Rady, P., Alves, T., & Rosas, R. C. (2007) · Infection Control and Hospital Epidemiology · doi:10.1086/513615 · Cited by 161
Thompson, G. R., Wiederhold, N. P., Vallor, A. C., Villareal, N. C., Lewis, J. S., & Patterson, T. F. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00473-08 · Cited by 159
Human Salivary Histatins: Promising Anti-Fungal Therapeutic Agents
Tsai, H., & Bobek, L. A. (1998) · Critical Reviews in Oral Biology & Medicine · doi:10.1177/10454411980090040601 · Cited by 155
Roetzer, A., Gabaldón, T., & Schüller, C. (2011) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2010.02102.x · Cited by 154
Ferrari, S., Sanguinetti, M., De Bernardis, F., Torelli, R., Posteraro, B., Vandeputte, P., & Sanglard, D. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01271-10 · Cited by 144
Autophagy supports Candida glabrata survival during phagocytosis
Roetzer, A., Gratz, N., Kovarik, P., & Schüller, C. (2010) · Cellular Microbiology · doi:10.1111/j.1462-5822.2009.01391.x · Cited by 142
Recent experience with fungaemia: change in species distribution and azole resistance
Chakrabarti, A., Chatterjee, S. S., Rao, K. L. N., Zameer, M., Rudramurthy, S. M., Singhi, S. C., Singh, R., & Varma, S. C. (2009) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540902777105 · Cited by 133
Candida and invasive candidiasis: back to basics
Lim, C. S. Y., Rosli, R., Seow, H. F., & Chong, P. P. (2011) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-011-1273-3 · Cited by 130
Nosocomial Candida glabrata Colonization: an Epidemiologic Study
Vázquez, J. A., Dembry, L. M., Sánchez, V., Vazquez, M. A., Sobel, J. D., Dmuchowski, C., & Zervos, M. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.2.421-426.1998 · Cited by 127
Iraqui, I., Garcia‐Sanchez, S., Aubert, S., Dromer, F., Ghigo, J., D’Enfert, C., & Janbon, G. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2004.04475.x · Cited by 126
Farahyar, S., Zaini, F., Kordbacheh, P., Rezaie, S., Safara, M., Raoofian, R., & Heidari, M. (2013) · DARU Journal of Pharmaceutical Sciences · doi:10.1186/2008-2231-21-1 · Cited by 125
Roetzer, A., Gregori, C., Jennings, A. M., Quintin, J., Ferrandon, D., Butler, G., Kuchler, K., Ammerer, G., & Schüller, C. (2008) · Molecular Microbiology · doi:10.1111/j.1365-2958.2008.06301.x · Cited by 124
Luo, G., & Samaranayake, L. P. (2002) · Apmis · doi:10.1034/j.1600-0463.2002.1100902.x · Cited by 121
Rai, M. N., Balusu, S., Gorityala, N., Dandu, L., & Kaur, R. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002863 · Cited by 117
Vandeputte, P., Tronchin, G., Larcher, G., Ernoult, E., Bergès, T., Chabasse, D., & Bouchara, J.-P. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00423-08 · Cited by 117
Arendrup, M. C., Perlin, D. S., Jensen, R. H., Howard, S. J., Goodwin, J., & Hope, W. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06369-11 · Cited by 117
Identifying infection-associated genes of Candida albicans in the postgenomic era
Wilson, D., Thewes, S., Zakikhany, K., Fradin, C., Albrecht, A., Almeida, R., Brunke, S., Grosse, K., Martin, R., Mayer, F., et al. (2009) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2009.00524.x · Cited by 115
Contribution of CgPDR1-Regulated Genes in Enhanced Virulence of Azole-Resistant Candida glabrata
Ferrari, S., Sanguinetti, M., Torelli, R., Posteraro, B., & Sanglard, D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017589 · Cited by 110
Ueno, K., Matsumoto, Y., Uno, J., Sasamoto, K., Sekimizu, K., Kinjo, Y., & Chibana, H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024759 · Cited by 109
Vandeputte, P., Tronchin, G., Bergès, T., Hennequin, C., Chabasse, D., & Bouchara, J.-P. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01510-06 · Cited by 109
Candida glabrata and Candida albicans co‐infection of an in vitro oral epithelium
Silva, S., Henriques, M., Hayes, A., Oliveira, R., Azeredo, J., & Williams, D. W. (2011) · Journal of Oral Pathology & Medicine · doi:10.1111/j.1600-0714.2010.00981.x · Cited by 108
Self-citationFungal infections associated with HIV infection
Samaranayake, L. P., Fidel, P., Naglik, Sweet, S., Teanpaisan, R., Coogan, M. M., Blignaut, E., & Wanzala, P. (2002) · Oral Diseases · doi:10.1034/j.1601-0825.8.s2.6.x · Cited by 107
Salivary Histatin 5 and its Similarities to the Other Antimicrobial Proteins in Human Saliva
Edgerton, M., & Koshlukova, S. E. (2000) · Advances in Dental Research · doi:10.1177/08959374000140010201 · Cited by 104
Negri, M., Martins, M. I. B. C., Henriques, M., Svidzinski, T. I. E., Azeredo, J., & Oliveira, R. (2009) · Mycopathologia · doi:10.1007/s11046-009-9246-0 · Cited by 103
Self-citationIn Vitro Biofilm Activity of Non-Candida albicans Candida Species
Silva, S. M., Henriques, M., Oliveira, R., Williams, D. W., & Azeredo, J. (2010) · Current Microbiology · doi:10.1007/s00284-010-9649-7 · Cited by 96
Self-citationChen, K.-H., Miyazaki, T., Tsai, H., & Bennett, J. E. (2006) · Gene · doi:10.1016/j.gene.2006.08.010 · Cited by 96
Host factors and oral candidosis.
Samaranayake, L., & MacFarlane, T. W. (1990) · Cited by 92
Genomewide Expression Profile Analysis of the Candida glabrata Pdr1 Regulon
Caudle, K. E., Barker, K. S., Wiederhold, N. P., Xu, L., Homayouni, R., & Rogers, P. D. (2010) · Eukaryotic Cell · doi:10.1128/ec.00073-10 · Cited by 92
Regulation of Candida glabrata oxidative stress resistance is adapted to host environment
Roetzer, A., Klopf, E., Gratz, N., Marcet-Houben, M., Hiller, E., Rupp, S., Gabaldón, T., Kovarik, P., & Schüller, C. (2011) · FEBS Letters · doi:10.1016/j.febslet.2010.12.006 · Cited by 90
Roles of Calcineurin and Crz1 in Antifungal Susceptibility and Virulence of Candida glabrata
Miyazaki, T., Yamauchi, S., Inamine, T., Nagayoshi, Y., Saijo, T., Izumikawa, K., Seki, M., Kakeya, H., Yamamoto, Y., Yanagihara, K., et al. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01364-09 · Cited by 88
Shin, J. H., Chae, M. J., Song, J. W., Jung, S.-I., Cho, D., Kee, S. J., Kim, S. H., Shin, M. G., Suh, S. P., & Ryang, D. W. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.00381-07 · Cited by 86
Invasive Candidiasis: An Overview from Taiwan
Ruan, S., & Hsueh, P. (2009) · Journal of the Formosan Medical Association · doi:10.1016/s0929-6646(09)60091-7 · Cited by 85
Jayatilake, J. A. M. S., Samaranayake, Y. H., Cheung, L. K., & Samaranayake, L. P. (2006) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.2006.00435.x · Cited by 84
Klionsky, D. J. (2004) · Nature · doi:10.1038/431031a · Cited by 82
In vitro proteinase production by Candida species
Chakrabarti, A., Nayak, N., & Talwar, P. (1991) · Mycopathologia · doi:10.1007/bf00437209 · Cited by 79
Introduction and Historical Perspectives
Abeles, F. B., Morgan, P. W., & Saltveit, M. E. (1992) · Elsevier eBooks · doi:10.1016/b978-0-08-091628-6.50007-2 · Cited by 79
Muller, H., Thierry, A., Coppée, J.-Y., Gouyette, C., Hennequin, C., Sismeiro, O., Talla, E., Dujon, B., & Fairhead, C. (2009) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2008.11.006 · Cited by 78
Das, V. M., & Ballal, M. (2008) · Revista Iberoamericana de Micología · doi:10.1016/s1130-1406(08)70050-0 · Cited by 78
Regulation of the CgPdr1 Transcription Factor from the Pathogen Candida glabrata
Paul, S., Schmidt, J. A., & Moye-Rowley, W. S. (2011) · Eukaryotic Cell · doi:10.1128/ec.00277-10 · Cited by 78
Proteomics of drug resistance in Candida glabrata biofilms
Seneviratne, C. J., Wang, Y., Jin, L., Abiko, Y., & Samaranayake, L. P. (2010) · PROTEOMICS · doi:10.1002/pmic.200900611 · Cited by 74
van Dyk, D., Pretorius, I. S., & Bauer, F. F. (2004) · Genetics · doi:10.1534/genetics.104.033704 · Cited by 74
Calcagno-Pizarelli, A. M., Bignell, E., Warn, P. A., Jones, M. D., Denning, D. W., Mühlschlegel, F. A., Rogers, T. R., & Haynes, K. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03755.x · Cited by 71
Bacterial lipopolysaccharides variably modulate in vitro biofilm formation of Candida species
Bandara, H. M. H. N., Lam, O. L. T., Watt, R. M., Jin, L. J., & Samaranayake, L. P. (2010) · Journal of Medical Microbiology · doi:10.1099/jmm.0.021832-0 · Cited by 68
Fungal Infections in Solid Organ Transplant Patients
Hagerty, J. A., Ortiz, J., Reich, D. J., & Manzarbeitia, C. (2003) · Surgical Infections · doi:10.1089/109629603322419607 · Cited by 68
Vale-Silva, L., Ischer, F., Leibundgut-Landmann, S., & Sanglard, D. (2013) · Infection and Immunity · doi:10.1128/iai.00074-13 · Cited by 65
Nakagawa, Y., Kanbe, T., & Mizuguchi, I. (2003) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2003.tb03376.x · Cited by 63
Lin, C.-Y., Chen, Y.-C., Lo, H.-J., Chen, K.-W., & Li, S.-Y. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.00699-07 · Cited by 62
Pathogenesis and Antifungal Drug Resistance of the Human Fungal Pathogen Candida glabrata
Tscherner, M., Schwarzmüller, T., & Kuchler, K. (2011) · Pharmaceuticals · doi:10.3390/ph4010169 · Cited by 60
Skn7p is involved in oxidative stress response and virulence of Candida glabrata
Saijo, T., Miyazaki, T., Izumikawa, K., Mihara, T., Takazono, T., Kosai, K., Imamura, Y., Seki, M., Kakeya, H., Yamamoto, Y., et al. (2010) · Mycopathologia · doi:10.1007/s11046-009-9233-5 · Cited by 59
Rajendran, R., Robertson, D. P., Hodge, P., Lappin, D., & Ramage, G. (2010) · Mycopathologia · doi:10.1007/s11046-010-9319-0 · Cited by 59
Shahi, P., & Moye-Rowley, S. (2008) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2008.12.012 · Cited by 56
Wisplinghoff, H., Seifert, H., Wenzel, R. P., & Edmond, M. B. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01318.x · Cited by 55
Electrophoretic karyotypes of Torulopsis glabrata
Kaufmann, C. S., & Merz, W. G. (1989) · Journal of Clinical Microbiology · doi:10.1128/jcm.27.10.2165-2168.1989 · Cited by 54
Adhesion of differentCandidaspp. to plastic: XTT formazan determinations
Hawser, S. (1996) · Medical Mycology · doi:10.1080/02681219680000721 · Cited by 54
Kraneveld, E. A., de Soet, J. J., Deng, D. M., Dekker, H. L., de Koster, C. G., Klis, F. M., Crielaard, W., & de Groot, P. W. J. (2011) · Mycopathologia · doi:10.1007/s11046-011-9446-2 · Cited by 50
Fungal killing by mammalian phagocytic cells
Nicola, A. M., Casadevall, A., & Goldman, D. L. (2008) · Current Opinion in Microbiology · doi:10.1016/j.mib.2008.05.011 · Cited by 49
Halliwell, S., Smith, M. C. A., Muston, P., Holland, S. L., & Avery, S. V. (2011) · Eukaryotic Cell · doi:10.1128/ec.05232-11 · Cited by 46
Thierry, A., Bouchier, C., Dujon, B., & Richard, G.-F. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn594 · Cited by 45
New regulators of biofilm development in Candida glabrata
Riera, M., Mogensen, E., d’Enfert, C., & Janbon, G. (2012) · Research in Microbiology · doi:10.1016/j.resmic.2012.02.005 · Cited by 43
Phospholipase and proteinase activities of Candida isolates from denture wearers
Marcos‐Arias, C., Eraso, E., Madariaga, L., Aguirre, J. M., & Quindós, G. (2009) · Mycoses · doi:10.1111/j.1439-0507.2009.01812.x · Cited by 43
Fatores de virulência de Candida spp isoladas de cateteres venosos e mãos de servidores hospitalares
Tamura, N. K., Negri, M., Bonassoli, L. A., & Svidzinski, T. I. E. (2007) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/s0037-86822007000100021 · Cited by 42
Kalkancı, A., Güzel, A. B., Khalil, I. I., Aydın, M., İlkit, M., & Kuştımur, S. (2012) · Medical Mycology · doi:10.3109/13693786.2012.662597 · Cited by 42
STB5 Is a Negative Regulator of Azole Resistance in Candida glabrata
Noble, J. A., Tsai, H., Suffis, S. D., Su, Q., Myers, T. G., & Bennett, J. E. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01278-12 · Cited by 40
Luo, G., Samaranayake, L. P., Cheung, B. P. K., & Tang, G. (2004) · Apmis · doi:10.1111/j.1600-0463.2004.apm11204-0509.x · Cited by 39
Gulshan, K., Lee, S. S., & Moye-Rowley, S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.251298 · Cited by 39
Bader, O., Schwarz, A., Kraneveld, E. A., Tangwattanchuleeporn, M., Schmidt, P., Jacobsen, M. D., Gross, U., De Groot, P. W. J., & Weig, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052218 · Cited by 39
Candida glabrata tryptophan‐based pigment production via the Ehrlich pathway
Brunke, S., Seider, K., Almeida, R. S., Heyken, A., Fleck, C. B., Brock, M., Barz, D., Rupp, S., & Hube, B. (2010) · Molecular Microbiology · doi:10.1111/j.1365-2958.2010.07052.x · Cited by 37
Gutiérrez-Escribano, P., Zeidler, U., Suárez, M. B., Bachellier‐Bassi, S., Clemente‐Blanco, A., Bonhomme, J., de Aldana, C. R. V., d’Enfert, C., & Correa‐Bordes, J. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002683 · Cited by 35
Karyotyping of Candida albicans and Candida glabrata from patients with Candida sepsis
Klempp‐Selb, Rimek, & Kappe (2000) · Mycoses · doi:10.1046/j.1439-0507.2000.00555.x · Cited by 35
Niimi, M., Kamiyama, A., & TOKUNAGA, M. (1988) · Medical Mycology · doi:10.1080/02681218880000271 · Cited by 32
Impact of the transcriptional regulator, Ace2, on the Candida glabrata secretome
Stead, D., Walker, J., Holcombe, L. J., Gibbs, S. R. S., Yin, Z., Selway, L., Butler, G., Brown, A. J. P., & Haynes, K. (2009) · PROTEOMICS · doi:10.1002/pmic.200800706 · Cited by 29
Magee, B. B., Sanchez, M. D., Saunders, D., Harris, D. J., Berriman, M., & Magee, P. T. (2007) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2007.07.004 · Cited by 28
de Almeida-Apolonio, A. A., Mesquita, C. S. S., Svidzinski, T. I. E., & de Oliveira, K. M. P. (2013) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/0037-8682-0074-2012 · Cited by 27
The inositol regulon controls viability in Candida glabrata
Bethea, E. K., Carver, B. J., Montedonico, A. E., & Reynolds, T. B. (2009) · Microbiology · doi:10.1099/mic.0.030072-0 · Cited by 26
Sikora, M., Dąbkowska, M., Swoboda‐Kopeć, E., Jarzynka, S., Netsvyetayeva, I., Jaworska-Zaremba, M., Pertkiewicz, M., & Młynarczyk, G. (2011) · Folia Microbiologica · doi:10.1007/s12223-011-0023-3 · Cited by 24
Roles of Cellular Respiration, Cg CDR1 , and Cg CDR2 in Candida glabrata Resistance to Histatin 5
Helmerhorst, E. J., Venuleo, C., Sanglard, D., & Oppenheim, F. G. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.3.1100-1103.2006 · Cited by 20
Stress Response in Candida Glabrata : Pieces of a Fragmented Picture
Jandric, Z., & Schüller, C. (2011) · Future Microbiology · doi:10.2217/fmb.11.131 · Cited by 19
Electrophoretic Karyotyping and Triazole Susceptibility of Candida glabrata Clinical Isolates
Barchiesi, F., Francesco, L. F. D., Arzeni, D., Caselli, F., Gallo, D., & Scalise, G. (1999) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s100960050255 · Cited by 18
Torulopsis glabrata an emerging yeast pathogen in cancer patients
Krcmery, V. (1999) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(98)00066-1 · Cited by 16
Oxidative stress response and virulence factors in Candida glabrata clinical isolates
Berila, N., Hyroššová, P., & Šubík, J. (2011) · Folia Microbiologica · doi:10.1007/s12223-011-0016-2 · Cited by 8
Flagged first, then by citations
Research works printed but not linked: 1
- Helmerhorst EJ, Oppenheim FG (2004) The antifungal mechanisms of antimicrobial proteins. In: Hancock REW, Devine D (eds) Mammalian antimicrobial proteins, 1st edn. Cambridge University Press, Cambridge, pp 245–277
Cited by
Sorted by citations
Candida sp. Infections in Patients with Diabetes Mellitus
Rodrigues, C. F., Rodrigues, M. E., & Henriques, M. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8010076 · Cited by 350
Self-citationYeast diversity of sourdoughs and associated metabolic properties and functionalities
Vuyst, L. D., Harth, H., Kerrebroeck, S. V., & Leroy, F. (2016) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2016.07.018 · Cited by 306
Candida Species Biofilms’ Antifungal Resistance
Silva, S. M., Rodrigues, C. F., Araújo, D., Rodrigues, M. E., & Henriques, M. (2017) · Journal of Fungi · doi:10.3390/jof3010008 · Cited by 317
Self-citationGeddes‐McAlister, J., & Shapiro, R. S. (2018) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13739 · Cited by 162
Drug-Resistant Candida glabrata Infection in Cancer Patients
Farmakiotis, D., Tarrand, J. J., & Kontoyiannis, D. P. (2014) · Emerging Infectious Diseases · doi:10.3201/eid2011.140685 · Cited by 152
Metadata
- Authors
- Rodrigues, C. F., Silva, S., & Henriques, M.
- Affiliations
- Institute for Biotechnology and Bioengineering (PT)
- Corresponding author
- Henriques, M.
- Venue
- European Journal of Clinical Microbiology & Infectious Diseases
- Published
- 2013-11-19
- Volume
- 33
- Issue
- 5
- Pages
- 673-688
- ISSN
- 0934-9723 (ISSN-L)
- 1435-4373
- OpenAlex
- W2099290964
- Cited by
- 268
- References
- 155
- Citations by year
- 2026: 11 · 2025: 10 · 2024: 23 · 2023: 17 · 2022: 25 · 2021: 28 · 2020: 27 · 2019: 24 · 2018: 34 · 2017: 24 · 2016: 19 · 2015: 16 · 2014: 10
- FWCI
- 1.95
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- other-oa
- www.springer.com/tdm (tdm)
- Locations
- European Journal of Clinical Microbiology & Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Life Sciences › Immunology and Microbiology › Microbiology › Yeasts and Rust Fungi Studies
- Keywords
- Candida glabrata, antifungal resistance, biofilm, candidiasis, bloodstream infection, immunosuppression, fungal pathogenesis, yeast biology
- MeSH terms
- Antifungal Agents, Candidiasis, Humans, Drug Resistance, Fungal, Candida glabrata
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review